121209-23-2

Upstream product

• 108-24-7 acetic anhydride 
• 121103-77-3 (E)-2,4-Dimethyl-3-oxo-5-phenyl-pent-4-enoic acid methyl ester 

Downstream Products

• 87265-69-8 (2S,3S,4R)-3-(tert-Butyl-dimethyl-silanyloxy)-4-methyl-5-trityloxy-pentan-2-ol 
• 121155-62-2 (3S,4R)-3-Hydroxy-4-methyl-5-trityloxy-pentan-2-one 
• 87265-74-5 (2R,3S)-2-Methyl-3-((R)-1-methyl-2-trityloxy-ethyl)-oxirane 
• 121129-17-7 (2R,3R,5R)-5-Methyl-3-((S)-1-methyl-2-trityloxy-ethyl)-hept-6-en-2-ol 
• 121103-82-0 (2R,3R,4R,6R)-2,4,6-Trimethyl-1-trityloxy-oct-7-en-3-ol 
• 121103-78-4 methyl (2S,3S,E)-3-hydroxy-2,4-dimethyl-5-phenylpent-4-enoate 
• 121103-78-4 (E)-(2R,3R)-3-Hydroxy-2,4-dimethyl-5-phenyl-pent-4-enoic acid methyl ester 

Relevant academic research and scientific papers

DETERMINATION OF ABSOLUTE STRUCTURE OF C16-C22 PART OF IRUMAMYCIN. CHIRAL SYNTHESIS OF DEGRADATION PRODUCT

Absolute structure of C16-C22 part of Irumamycin (1) was determined by comparing the degradation product 2 with the synthetic (+)-2.